A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

February 2, 2012

Primary Completion Date

August 20, 2015

Study Completion Date

August 20, 2015

Conditions
Carcinoma, Hepatocellular
Interventions
DRUG

Placebo

iv Days 1 and 8, and every 2 weeks thereafter

DRUG

GC33

1600 mg iv Day 1 and 8, and every 2 weeks thereafter

Trial Locations (57)

100

Auckland Hospital; New Zealand Liver Transplant Unit, Auckland

National Taiwan Uni Hospital; Dept of Oncology, Taipei

112

Taipei Veterans General Hospital, Taipei

1070

Hospital Erasme, Brussels

9000

UZ Gent, Ghent

10032

Columbia University Medical Center, New York

10065

Memorial Sloan Kettering Cancer Center, New York

10408

National Cancer Center, Gyeonggi-do

13353

Charité Uni.-medizin Berlin, Campus Virchow-Klinikum; Med. Klinik m.S. Hepatologie Gastroenterologie, Berlin

13385

Aphm; Hopital De La Conception, Marseille

20122

Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia, Milan

28007

Hospital General Universitario Gregorio Marañon; Servicio de Oncologia, Madrid

Hospital General Universitario Gregorio Marañon, Madrid

28040

Hospital Universitario Clínico San Carlos; Servicio de Oncologia, Madrid

28041

Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid

31059

Hopital Purpan;Gastro Enterologie Hepatologie, Toulouse

39008

Hospital Universitario Marques de Valdecilla; Servicio de Oncologia, Santander

40705

Taichung Veterans Gen Hosp, Taichung

48201

Barbara Ann Karmanos Cancer Institute, Detroit

49033

Hotel Dieu; Medecine A, Angers

50009

Hospital Universitario Miguel Servet; Servicio Hematologia, Zaragoza

54511

Hôpital d'Adultes; Service hépato-gastro-entérologie, Vandœuvre-lès-Nancy

60590

Klinik Johann Wolfgang von Goethe Uni; Zentrum der Inneren Medizin; Medizinische Klinik I, Frankfurt am Main

63110

Washington Univ School of Med; Barnes-Jewish Hospital; Siteman Cancer Center, St Louis

69120

Uni Heidelberg Med. Klinik; Innere Medizin IV, Heidelberg

75571

Hôpital Saint Antoine; Service Hépathologie, Paris

81675

Klinikum rechts der Isar der TU München; Klinikapotheke, München

82100

Azienda Ospedaliera G. Rummo; Unità Operativa di Oncologia Medica 1, Benevento

90095

UCLA Medical Center, Los Angeles

98104

Swedish Cancer Inst., Seattle

169610

National Cancer Centre; Medical Oncology, Singapore

20889-0001

National Cancer Institute; Ctr for Cancer Research, Bethesda

37232-7610

Vanderbilt Medical Center, Nashville

38 043

CHU de GRENOBLE; UF de Cancérologie, Grenoble

06202

Hopital de L'Archet; Pole de Reference Hepatite C, Nice

04103

Universitätsklinikum Leipzig, Leipzig

Unknown

Queen Mary Hospital; Dept of Surgery, Pokfulam

Prince of Wales Hosp; Dept. Of Clinical Onc, Shatin

00168

Policlinico Universitario Agostino Gemelli, Rome

277-8577

National Cancer Center Hospital East, Chiba

920-8641

Kanazawa University Hospital, Ishikawa

241-8515

Kanagawa Cancer Center, Kanagawa

589-8511

Kindai University Hospital, Osaka

104-0045

National Cancer Center Hospital, Tokyo

181-8611

Kyorin University Hospital, Tokyo

602-739

Pusan University Hospital, Busan

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

06591

Seoul St Mary's Hospital, Seoul

08035

Hospital Universitari Vall d'Hebron; Servicio de Hepatologia, Barcelona

08036

Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona

00833

Chang Gung Memorial Foundation - Kaohsiung, Kaohsiung City

00704

National Cheng Kung Univ Hosp, Tainan City

CH63 4JY

The Clatterbridge Cancer Ctr NHS Foundation Trust, Bebington

NW3 2QG

Royal Free Hospital; Dept of Oncology, London

SE5 9RS

King'S College Hospital; Haematology, London

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01507168 - A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter